Plasma concentrations of endothelium-associated proteins (EAP) (plasma fibronectin (PFN), angiotensin-converting enzyme, factor VIII-related antigen (F VIII-R : Ag)) and tissue plasminogen activator and serum thyroid hormone concentrations were studied in nine patients with anorexia nervosa (AN), before and after weight gain. Before weight gain (-35.9 (SE 2.3) YO of standard body-weight) PFN was significantly reduced and F VIII-R:Ag was significantly increased in AN patients compared with the concentrations in control subjects (211 5 (SE 14.9) v. 274.7 (SE 16.6) pg/ml, P < 0.05; 129.2 (SE 14.1) v. 88.2 (SE 9.7) %, P < 0.05 respectively). Serum triiodothyronine (T3) and free T3 levels were also significantly lower before weight gain in AN patients (0.85 (SE 0.07) v. 1.53 (SE 0.08) nmol/l, P < 0.001 ; 2.57 (5E 0.23) v. 5.31 (SE 0.34) pmol/l, P < 0.001 respectively), although serum thyroxine (T4), free T4, and thyrotropin concentrations were within the normal range throughout the study periods. Following weight gain, PFN and F VIII-R:Ag concentrations normalized as did the thyroid hormone levels. The incremental changes in PFN levels correlated significantly with those in serum thyroid hormone concentrations (T3, r 0.79, P < 0.01 ; free T3, r 0.84, P < 0.01). These findings suggest that PFN levels may be directly related to serum T3 concentrations in AN patients.
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). However, the interrelationships between the changes in thyroid hormone and EAP concentrations are not identical in those conditions. Furthermore, the relationship between the hormonal profile of A N patients and the degree of weight reduction and undernutrition is still unclear, although most endocrine alterations recover with re-feeding and weight gain (Newman & Halmi, 1988) . Therefore, serum thyroid hormone and EAP levels were measured in AN patients, when they were initially diagnosed and following restoration to normal body-weight, to gain further insight into these alterations and interrelationships.
S U B J E C T S A N D M E T H O D S

SubJect.r
Nine hospitali~ed patients (eight females and one male) who met the criteria for A N according to DSMTII-R (American Psychiatric Association, 1987) were studied. Briefly, they fulfilled the following conditions : ( I ) refusal to maintain body-weight over a minimal normal weight-for-age and height (1 5 YO below that expected), (2) intense fear of gaining weight or becoming fat, even though underweight, (3) disturbance in the way in which one's body-weight, size, or shape is experienced, (4) in females, absence of at least three consecutive menstrual cycles when otherwise expected to occur (primary or secondary amenorrhoea). As shown in Table 1 Study protocol All patients were in-patients on the ward of the Department of Psychosomatic Medicine at Kyushu University Hospital. They all gave informed consent for the study. All AN patients were treated by refeeding without medications. Weight gain was reinforced by cognitivebehaviour therapy and with continued psychotherapy. Their average energy intake commenced at 3.354.19 MJ/d, consisting of mixed food and tube feeding of elemental diet (Morishita Pharmaceutical Co. Ltd., Osaka), shortly after admission to the hospital. The daily diet was increased by 0.84 MJ every 2-3 weeks until they were ultimately eating 9.21-10.04 MJ/d of ordinary mixed food.
As noted in Table 1 , the study was divided into three phases: phase 1 was shortly after admission; phase 2 was at the time of 5 kg body-weight increase; and phase 3 was when they had attained an increase of 10 kg. Patients were weighed daily at 06.30 hours after they had voided. Most patients gained approximately 0.7-1.0 kg/week so phases 2 and 3 occurred at about 2 and 4 months respectively after admission to the hospital.
Assays
Serum triiodothyronine (T3) and thyroxine (T4) were measured by radioimmunoassay (RIA) (Dainabot, Matsudo City); free T3 and free T4 by RIA (Amersham International PIC, Amersham, Bucks., UK) ; thyroid-stimulating hormone (TSH) was measured by a highly sensitive IRMA (immuno-radiometric assay; Dainabot, Matsudo City). Thyroxinebinding protein (TBG) was measured by RIA, and assay for prealbumin was determined by the method of radial immunodiffusion. Total protein, albumin and blood chemistry studies were measured by an automated multiple-analysis system (Special Reference Laboratory, Tokyo). PFN was estimated by a kinetic immunoturbidimetric assay using rabbit antiserum against human PFN (Saba et al. 1981) . Serum angiotensin-converting enzyme (ACE) was measured by a colorimetric assay (Kasahara & Ashihara, 1981) using p-hydroxybenzoyl-glycine-L-histidyl-L-leucine as substrate (Fujebiro Pharmaceutical Co. Ltd, Tokyo). The F VIII-R : Ag concentration was measured by immunoelectrophoresis (Laurel], 1966) using anti-F VIII-R : Ag immunoglobulin G. Tissue plasminogen activator antigen (t-PA) in plasma was determined by the use of enzyme-linked immunosorbent assay (ELISA) (Bergsdorf et af. 1983) .
For all assays, the intra-and interassay coefficients of variation were less than 5 and LO % respectively.
Statistical analysis
All values are expressed as means with their standard errors. Results were evaluated by means of paired and unpaired non-parametric tests (all two-tailed). Correlations between variables were determined by Spearman's correlation coefficients. The level of significance was set at 5%. Table 2 shows mean plasma protein and metabolite concentrations throughout the study periods. All were within the normal range and no significant changes were observed. Table 3 shows changes in concentrations of serum thyroid hormones and TSH in AN patients during the period of study and in normal controls. Serum T3 and free T3 levels were significantly lower during the initial phase I compared with normal controls ( P < 
R E S U L T S
TBG, thyroxine-binding protein Phase 1, shortly after admission, phase 2, at the time of 5 kg body-weight increase 1 phdse 1, phase 3, dt the time of 10 kg body-weight increase 1 phase 1 * For details of patients, see Table I , for details of procedures, see p 69 Phase 1, shortly after admission; phase 2, at the time of 5 kg body-weight increase 1'. phase 1 ; phase 3, at the Mean values were significantly different from those of N C : 'P < 0.05, ***P < 0.001.
Mean values were significantly different from those of phase 1 : ttP < 0.01.
$ For details of patients, see Table 1 ; for details of procedures, see p. 69. time of 10 kg body-weight increase Y. phase I. 0.001) and increased significantly to be within the normal range at phases 2 and 3. Serum T4, free T4 and TSH concentrations were within the normal range throughout the study periods (the normal ranges :T3 1.2-2.8 nmol/l, T4 63-160 nmol/l, free T3 4.6-7.9 pmol/l, free T4 10.3-27.1 pmol/l, TSH 0.6-5.1 mU/l). Fig. 1 shows changes in concentration of EAPs. PFN was significantly decreased at phase 1 ( P < 0.05) and subsequently increased to be within the normal range following weight gain. On the other hand, F VIII-R:Ag was significantly increased at phase 1 (P < 0.05) and tended to decrease during restoration of body-weight. ACE levels were not Table I . For details of procedures, see p. 69. significantly different from control subjects throughout the study periods, although they increased significantly following weight gain. t-PA concentrations remained normal in AN patients throughout the period of study (the normal ranges : PFN 250460 pg/ml, ACE 8.3-21.4 U/1, F VTII-R :Ag 50-1 55 %, t-PA d 7.6 ng/ml).
Significant correlations were found with PFN and thyroid hormone concentrations in patients with AN (phase 1) and normal controls (n 17, T3, r 0.75, P < 0.01 : T4, r 0.59, P < 0.05; free T3, r 0.72, P < 0.01). Fig. 2 shows the relationships between PFN and serum T3 concentrations in them. Other EAPs showed, however, no significant correlations with thyroid hormones. Incremental changes (phase 2-phase ]/phase 1) in EAPs and thyroid hormones during weight gain in AN patients are shown in Table 4 . The changes of PFN correlated significantly with those of thyroid hormones (n 9, T3, r 0.79, P < 0.01 ; free T3, r 0.84, P < 0.01). The same was found in the incremental changes from phase 1 to phase 3. No significant correlations were observed with the other EAPs and thyroid hormone concentrations. The change of ACE was only significantly correlated with that of bodyweight ( r 0.69, P < 0.05). Table I , for details of procedures, sce p 69 t-PA, tissue plasminogen dctivdtor, T3, triiodothyronine, T4, thyroxine
DISCUSSION
In the present study, thyroid function in AN patients with severe weight loss demonstrated a 'low T3' state. This finding is confirmed by previous reports on AN patients (Newman & Halmi, 1988) . The nutritional state of AN patients, however, appears to be different from protein-energy malnutrition (Ingenbleek et al. 1972; Waterlow, 1972) , as indicated by concentrations of total protein and albumin as well as other rapid turnover hepaticallysynthesized proteins. Serum protein concentrations are seldom below normal in AN, and plasma aminograms have a normal appearance, which is quite unlike that observed in kwashiorkor or marasmus (Waterlow, 1972) . With regard to EAPs, PFN was significantly decreased and F VIII-R: Ag was increased when the AN patients were markedly underweight. The reductions in PFN are confirmed observed. This finding is similar to that reported in patients with diabetic ketoacidosis (Alexander et al. 1983 ), while no information was obtained regarding the correlations between PFN and serum T4 levels in those patients with a low T4 state. Based on the findings of the present study, the decreased T3 concentration can be explained by the concept 'low T3' state rather than hypothyroidism (Chopra et al. 1975 ). The 'low T3' state is attributed to the impairment of extravascular binding of T4 and its transport across the cell membrane, as well as to the defect of peripheral T4 conversion to T3 by 5'-deiodinase (EC 3 . 8 . 1 .4) (Van Der Hyden et al. 1986) . PFN concentrations increased to be within the normal range in association with restoration of body-weight and normalization of serum T3 concentrations. Accordingly, rather than PFN being an indicator of thyroid state, the parallel changes appear to be a reflection of the nutritional and metabolic state of AN patients during weight recovery.
On the other hand, conflicting information about the influence of thyroid hormone on fibronectin synthesis was noted in several experiments. While thyroid hormones inhibit cellular-type fibronectin synthesis by cultured human skin fibroblasts (Murata et al. 1987) , PFN levels are up-regulated by thyroid hormones (Graninger et ul. 1985 (Graninger et ul. , 1986 Azuma et al. 1987) . Certainly, as compared with PFN, cellular or tissue fibronectin is a less soluble form of fibronectin, localized in the extracellular matrix of many cells and in connective tissue matrices (Yamada, 1983) . The major source of PFN appears to be the liver (Tamkun & Hynes, 1983) ; however, factors regulating the PFN pool still remain uncertain (Yamada, 1983; Tamkun & Hynes, 1983) . In the present study it is improbable that the decreased hepatic PFN synthesis was simply attributed to the low thyroid hormone concentrations (Graninger et al. 1985) because there is not a simple cause-and-effect relationship between them (Alexander et ul. 1983) , and both the synthesis and catabolism of proteins are generally affected by thyroid hormones (Azume et al. 1987) . Hypothyroid patients have shown rather normal PFN levels (Graninger et al. 1985) . In addition, plasma concentrations of proteins known to be synthesized only by the hepatocytes were not decreased in AN patients. It seems possible that, as observed in trauma and burn patients (Saba & Jaffe, 1980) , not only synthesis but also catabolism or turnover of PFN, or both, may be changed in AN patients, thereby affecting the PFN pool. Taken together, although the elevation in PFN of AN patients during recovery may be mainly a direct reflection of increased hepatic synthesis following their ability to resume feeding, it requires further investigation to clarify the exact mechanism(s) of the synthesis and metabolism of PFN in those underweight patients.
Furthermore, all physiological functions of PFN have not been ideptified, although it is believed to be the primary non-specific circulating opsonin (Saba & Jaffe, 1980) . The reduction of PFN is reported in sepsis and multiple organ failure (Saba, 1986 ). Palmblad et al. (1 977) demonstrated impaired granulocyte bactericidal capacity and reduced granulocyte adherence in AN. PFN reduction in AN may contribute, at least in part, to dysfunction in the reticulo-endothelial system, although these patients are found to be less vulnerable to infection than are those suffering from other forms of malnutrition and weight loss (Bhanji & Mattingly, 1988) . Moreover none of the patients in the present study had any evidence of infection.
Other EAPs, including ACE, have also been reported to be appropriate indicators of thyroid hormone activity (Graninger et al. 1986 ); however, a direct correlation with serum thyroid hormone levels was not observed in our AN patients. Only the significant correlation with body-weight change was found. This observation is supported by our previous studies of AN patients (Matsubayashi et al. 1988 ) and acute starvation (Komaki c't al. 1988) . Other factors, such as the nutritional state and weight reduction, as well as the renin-angiotensin system might modify ACE levels.
Changes in F VfII-R: Ag activity have been also reported to correlate with thyroid function (Rogers et al. 1982; Graninger et al. 1986 ). In the present study, however, F VIII-R:Ag levels were increased in the 'low T3' state. Our subjects had no history of taking contraceptives. It is reported, in general, that this factor increases during the acute phase of various conditioqs such as malignancy, post-operative state, renal and liver disease (Lombardi et ul. 1981) , and during exercise (Prentice et al. 1972 ). Since it is recognized that many AN patients exercise vigorously (Kron et al. 1978; Bhanji & Mattingly, 1988) , the activity of our patients was closely monitored 24 h/d on the ward to prevent hyperactivity and other various abnormal behaviours during hospitalization. However, no evidence of hyperactivity was found during this study period. Further study is necessary to clarify the mechanism of the increase in F VIII-R : Ag concentrations in AN.
In conclusion, these findings suggest that PFN concentrations may be directly related to those of serum T3 during weight recovery with adequate nutrition in anorexia nervosa, whereas other EAPs are changed with no obvious relationships.
